Pharmaceutical Digital Innovation Index
This annual index reveals how the top companies are leveraging digital advancements to accelerate development, improve patient engagement, and drive impactful change in healthcare.
2026 Digital Innovation Index
The 2026 results launched live at the CNS Summit in Boston.
-
- Sanofi 2
- 2025 3rd
- 2024 7th
- 1
- Eli Lilly 8
- 2025 10th
- 2024 12th
- 2
- AstraZeneca 1
- 2025 2nd
- 2024 2nd
- 3
- Chugai 24
- 2025 28th
- 2024
- 4
- Roche 4
- 2025 1st
- 2024 1st
- 5
- Bristol-Myers Squibb 2
- 2025 8th
- 2024 3rd
- 6
- Novo 5
- 2025 12th
- 2024 5th
- 7
- Johnson & Johnson 1
- 2025 9th
- 2024 9th
- 8
- Boehringer Ingelheim 2
- 2025 11th
- 2024 8th
- 9
- Merck KGaA 10
- 2025 20th
- 2024 10th
- 10
- Sanofi 2
Resources
-
Innovation
Welcome to the Trough: Where AI in Pharma Gets Real or Goes Home
For the last two years, AI in pharma has ridden high on the hype cycle.
Read article -
Innovation
A virtual Chief Commercial Officer (vCCO)
The best marketer in the pharmaceutical industry can't market anything by themselves.
Read article
Download the report
The Pharmaceutical Digital Invention Index, and the accompanying report, explore the performance of individual companies in much greater detail. By accessing our report in full, you are given an inside look into our research and findings.
- 1 Methodology and analysis
- 2 Extended profiles of the Top 10 overall companies
- 3 The report in full
- 4 Ranking of performance in: Commercial, Clinical & Research
Have an opinion?
We’d love to hear your thoughts. We are open to further discussion and encourage questions and comments about our rankings. Please give us a shout to continue the conversation, we are here to answer.